Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients.
Belluti S, Semeghini V, Rigillo G, Ronzio M, Benati D, Torricelli F, Reggiani Bonetti L, Carnevale G, Grisendi G, Ciarrocchi A, Dominici M, Recchia A, Dolfini D, Imbriano C.
Belluti S, et al. Among authors: benati d.
J Exp Clin Cancer Res. 2021 Nov 15;40(1):362. doi: 10.1186/s13046-021-02166-4.
J Exp Clin Cancer Res. 2021.
PMID: 34782004
Free PMC article.